These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Myofiber length and three-dimensional localization of NMJs in normal and botulinum toxin treated adult extraocular muscles. Harrison AR; Anderson BC; Thompson LV; McLoon LK Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3594-601. PubMed ID: 17652728 [TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin-induced myopathy in the rat. Hassan SM; Jennekens FG; Veldman H Brain; 1995 Apr; 118 ( Pt 2)():533-45. PubMed ID: 7735893 [TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia. Figgitt DP; Noble S Drugs; 2002; 62(4):705-22. PubMed ID: 11893235 [TBL] [Abstract][Full Text] [Related]
27. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Borodic GE; Ferrante R; Pearce LB; Smith K Mov Disord; 1994 Jan; 9(1):31-9. PubMed ID: 8139603 [TBL] [Abstract][Full Text] [Related]
28. Can previously injected botulinum toxin cause paradoxical masseter muscle rigidity after administration of a nondepolarizing neuromuscular blocking agent? Lee JY; Seo KH Can J Anaesth; 2024 Feb; 71(2):294-295. PubMed ID: 37853281 [No Abstract] [Full Text] [Related]
30. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Shaari CM; Sanders I Muscle Nerve; 1993 Sep; 16(9):964-9. PubMed ID: 8355728 [TBL] [Abstract][Full Text] [Related]
31. [Injection of botulinum toxin as a new treatment of torticollis]. Aquilonius SM; Cesarini KG; StÄlberg E Lakartidningen; 1990 Dec; 87(51-52):4408-10. PubMed ID: 2177127 [TBL] [Abstract][Full Text] [Related]
32. Ultrasonographic observation of the masseter muscle after injection of different botulinum toxin type A. Li Z; Li Z; Li Y; Dong R; Chen C; Huang J; Xia Z; Yu N; Long X J Cosmet Dermatol; 2022 Nov; 21(11):5555-5561. PubMed ID: 35599608 [TBL] [Abstract][Full Text] [Related]
33. Changes of masseter muscle activity following injection of botulinum toxin type A in adult rats. Tsai CY; Lei YY; Yang LY; Chiu WC Orthod Craniofac Res; 2015 Nov; 18(4):202-11. PubMed ID: 26083593 [TBL] [Abstract][Full Text] [Related]
34. Dissociation between nerve-muscle transmission and nerve trophic effects on rat diaphragm using type D botulinum toxin. Bray JJ; Harris AJ J Physiol; 1975 Dec; 253(1):53-77. PubMed ID: 54420 [TBL] [Abstract][Full Text] [Related]
35. Ultrastructural responses of the hypoglossal nucleus to the presence in the tongue of botulinum toxin, a quantitative study. Sumner BE Exp Brain Res; 1977 Nov; 30(2-3):313-21. PubMed ID: 202476 [TBL] [Abstract][Full Text] [Related]
36. [Botulinum toxin in therapy of craniocervical dystonia]. Dressler D; Benecke R; Conrad B Nervenarzt; 1989 Jul; 60(7):386-93. PubMed ID: 2668776 [TBL] [Abstract][Full Text] [Related]
37. A Cadaveric Study of Dye Spreading: Determining the Ideal Injection Pattern for Masseter Hypertrophy. Sermswan P; Tansatit T; Meevassana J; Panchaprateep R Dermatol Surg; 2021 Oct; 47(10):1354-1358. PubMed ID: 34417381 [TBL] [Abstract][Full Text] [Related]
38. The treatment of masseter hypertrophy with botulinum toxin type A. Al-Ahmad HT; Al-Qudah MA Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107 [TBL] [Abstract][Full Text] [Related]
39. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate. Kwon JS; Kim ST; Jeon YM; Choi JH Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136 [TBL] [Abstract][Full Text] [Related]
40. Commentary: The effect of botulinum toxin type A injection on lower facial contouring evaluated using a three-dimensional laser scan. Ahn KY Dermatol Surg; 2010 Dec; 36 Suppl 4():2167. PubMed ID: 21244566 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]